Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients Manassas, VA, July 13, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. announced today that results from the first prospective longitudinal pilot study of daily, home-based self-imaging with their...

AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials Manassas, VA, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. announced today that the company will provide AsclepiX Therapeutics with Home OCT monitoring services through its Notal Vision...

Home OCT longitudinal home-based study with patient self-operated device has begun Manassas, VA, June 17, 2020 (GLOBE NEWSWIRE) -- Notal Vision is proud to announce the enrollment of patients in the first longitudinal home-based study with its investigational home optical...